Search

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it

GLP-1 medication after a year," says [Dr. Jaime Almandoz](https://utswmed.org/doctors/jaime-almandoz/), an obesity

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

GLP-1 medications are sold under several different brand names and treat diabetes, obesity and sleep

New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs

obesity medication maintained more muscle while still losing fat, body scans showed. Experts say more evaluation studies are needed though, before recommending it. People on GLP-1

U.S. seizes Iranian cargo ship. And, tariff refund portal launches

GLP-1 medications like Ozempic and Zepbound are intended for lifelong use to treat chronic conditions like diabetes and obesity

Restrictions on obesity drug coverage force patients to pivot

obesity medication. **Jodi Hilton for NPR** Jodi Hilton for NPR For Meghan Lena, a special ed teacher in Massachusetts, the letter she got last spring from the company that manages her drug benefits really hurt

A new Medicare option for weight loss drugs is coming: Here's what to know

GLP-1 medications approved for weight loss: the pill and injectable formulations of Wegovy, the KwikPen formulation of Zepbound, and the [Foundayo pill](https://www.npr.org/2026/04/01/nx-s1-5760899/weight-loss-pill-foundayo). [![A bottle of Foundayo pills, a new obesity

Weight-loss drugs may prevent thousands of knee replacements, study suggests

GLP-1 medications for one year was associated with a 1.4-percentage-point reduced risk of knee replacement surgery at the three-year follow-up point and a 2.8-percentage-point lower risk after eight

Want obesity drugs covered by insurance? Telehealth companies have a big say

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might](https://www.npr.org/2026/01/27/nx-s1-5689019/glp-1-ozempic-wegovy-zepbound-mounjaro-obesity-precision-medicine) "I thought, 'All right, I'll go through their hoops — I'll jump through their hoops

Daily pill to help keep weight off after stopping obesity jabs

GLP-1 based weight loss medications – that patients experience significant weight rebound after stopping them. "What is also important to note is that the decrease in blood pressure, lipids and blood glucose were also maintained

Wegovy weight-loss pill approved in UK

GLP-1 drugs are not meant for a short-term or cosmetic weight loss, and health experts [strongly advise against](https://www.bbc.co.uk/news/articles/c4nnj0wrl49o) using them as a quick-fix to get "beach body" ready, although

New weight-loss shot appears to outperform other obesity drugs on market

obesity – including 37.5% of individuals who began the trial with a BMI of 40 or higher. Based on Eli Lilly’s trial, weight loss with retatrutide appears to exceed what has been typically possible with

Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies

obesity treatments. Ethics filings revealed several thousand trades on the US president’s behalf tied to stocks and bonds in the first quarter of 2026, with a cumulative ​value of between $220m and around $750m

Wegovy weight-loss pills to be available for patients in UK to buy

GLP-1 receptor agonist tablet for weight-loss to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA), making the UK the third country to authorise the pills, behind